Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation

Background. Adoption of machine perfusion (MP) technology has rapidly expanded in liver transplantation without real-world data on utilization and outcomes, which are critical to understand the appropriate application of MP technology. Methods. The Organ Procurement and Transplant Network/Standard T...

Full description

Saved in:
Bibliographic Details
Main Authors: Steven A. Wisel, MD, Justin A. Steggerda, MD, Irene K. Kim, MD
Format: Article
Language:English
Published: Wolters Kluwer 2024-12-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001726
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846156276263813120
author Steven A. Wisel, MD
Justin A. Steggerda, MD
Irene K. Kim, MD
author_facet Steven A. Wisel, MD
Justin A. Steggerda, MD
Irene K. Kim, MD
author_sort Steven A. Wisel, MD
collection DOAJ
description Background. Adoption of machine perfusion (MP) technology has rapidly expanded in liver transplantation without real-world data on utilization and outcomes, which are critical to understand the appropriate application of MP technology. Methods. The Organ Procurement and Transplant Network/Standard Transplant Analysis and Research database was used to identify all deceased donor livers procured with intent for transplant between October 27, 2015 (date of first recorded MP) and June 30, 2023 (n = 67 795). Liver allografts were cohorted by donation after brain death (DBD; n = 59 957) or circulatory death (DCD; n = 7873) and analyzed by static cold storage (SCS) or MP preservation method. Donor demographics, organ utilization, and graft survival were evaluated. Results. By 2023, 12.5% of all livers and 37.2% of DCD livers underwent MP preservation (82.6% normothermic, 6.7% hypothermic, and 10.8% other/unknown). Compared with SCS, MP liver donors were older (DBD: 48 versus 40 y [P < 0.001]; DCD: 43 versus 38 y [P < 0.001]) with higher body mass index (DBD: 28.8 versus 26.9 kg/m2 [P < 0.001]; DCD: 27.7 versus 26.9 kg/m2 [P = 0.004]). Donor livers had similar levels of macrosteatosis (median 5%). Graft utilization was higher for MP than SCS after DBD (96.4% versus 93.0%, P < 0.001) and DCD (91.4% versus 70.3%, P < 0.001) donation. Graft survival was similar between MP and SCS livers from DBD donors (P = 0.516), whereas MP-preserved grafts had superior survival from DCD donors at 1 and 3 y posttransplant (P = 0.013 and 0.037). Patient survival was similar across all groups at 3 y (P = 0.322). Conclusions. The use of MP in liver transplantation increased rates of liver utilization and improved graft survival after DCD. Further monitoring of MP outcomes is required to understand long-term benefits.
format Article
id doaj-art-e3e6de8a828b4778833e18d04b4d27b0
institution Kabale University
issn 2373-8731
language English
publishDate 2024-12-01
publisher Wolters Kluwer
record_format Article
series Transplantation Direct
spelling doaj-art-e3e6de8a828b4778833e18d04b4d27b02024-11-26T08:06:37ZengWolters KluwerTransplantation Direct2373-87312024-12-011012e172610.1097/TXD.0000000000001726202412000-00004Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver TransplantationSteven A. Wisel, MD0Justin A. Steggerda, MD1Irene K. Kim, MD21 Comprehensive Transplant Center, Jim and Eleanor Randall Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.1 Comprehensive Transplant Center, Jim and Eleanor Randall Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.1 Comprehensive Transplant Center, Jim and Eleanor Randall Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.Background. Adoption of machine perfusion (MP) technology has rapidly expanded in liver transplantation without real-world data on utilization and outcomes, which are critical to understand the appropriate application of MP technology. Methods. The Organ Procurement and Transplant Network/Standard Transplant Analysis and Research database was used to identify all deceased donor livers procured with intent for transplant between October 27, 2015 (date of first recorded MP) and June 30, 2023 (n = 67 795). Liver allografts were cohorted by donation after brain death (DBD; n = 59 957) or circulatory death (DCD; n = 7873) and analyzed by static cold storage (SCS) or MP preservation method. Donor demographics, organ utilization, and graft survival were evaluated. Results. By 2023, 12.5% of all livers and 37.2% of DCD livers underwent MP preservation (82.6% normothermic, 6.7% hypothermic, and 10.8% other/unknown). Compared with SCS, MP liver donors were older (DBD: 48 versus 40 y [P < 0.001]; DCD: 43 versus 38 y [P < 0.001]) with higher body mass index (DBD: 28.8 versus 26.9 kg/m2 [P < 0.001]; DCD: 27.7 versus 26.9 kg/m2 [P = 0.004]). Donor livers had similar levels of macrosteatosis (median 5%). Graft utilization was higher for MP than SCS after DBD (96.4% versus 93.0%, P < 0.001) and DCD (91.4% versus 70.3%, P < 0.001) donation. Graft survival was similar between MP and SCS livers from DBD donors (P = 0.516), whereas MP-preserved grafts had superior survival from DCD donors at 1 and 3 y posttransplant (P = 0.013 and 0.037). Patient survival was similar across all groups at 3 y (P = 0.322). Conclusions. The use of MP in liver transplantation increased rates of liver utilization and improved graft survival after DCD. Further monitoring of MP outcomes is required to understand long-term benefits.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001726
spellingShingle Steven A. Wisel, MD
Justin A. Steggerda, MD
Irene K. Kim, MD
Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation
Transplantation Direct
title Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation
title_full Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation
title_fullStr Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation
title_full_unstemmed Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation
title_short Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation
title_sort use of machine perfusion in the united states increases organ utilization and improves dcd graft survival in liver transplantation
url http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001726
work_keys_str_mv AT stevenawiselmd useofmachineperfusionintheunitedstatesincreasesorganutilizationandimprovesdcdgraftsurvivalinlivertransplantation
AT justinasteggerdamd useofmachineperfusionintheunitedstatesincreasesorganutilizationandimprovesdcdgraftsurvivalinlivertransplantation
AT irenekkimmd useofmachineperfusionintheunitedstatesincreasesorganutilizationandimprovesdcdgraftsurvivalinlivertransplantation